Evidence map›Paper›PMID 41333490›Full record

ArticleCureus2025

Primary Small-Cell Neuroendocrine Carcinoma of the Vagina: A Case Report and Literature Review.

Vishal Bahall, Lance De Barry, Triston De Barry

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Vishal BahallObstetrics and Gynaecology, The University of the West Indies, St. Augustine, TTO.
Lance De BarryObstetrics and Gynaecology, San Fernando General Hospital, San Fernando, TTO.
Triston De BarryInternal Medicine, San Fernando General Hospital, San Fernando, TTO.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Small-cell neuroendocrine carcinoma (SCNC) of the vagina is an exceedingly rare and highly aggressive tumor of the female genital tract. The vast majority of SCNCs occur outside the female genital tract, with gynecological involvement being remarkably rare. Despite modern advances in tumor genomic profiling, SCNC continues to demonstrate an aggressive clinical course and remains associated with an unfavorable prognosis. A 63-year-old woman presented to the Gynecology clinic with postmenopausal bleeding following a total abdominal hysterectomy with right salpingo-oophorectomy for uterine fibroids and a benign right ovarian cyst several years before. On assessment, a vaginal wall mass was discovered, and subsequent biopsy with histopathological assessment demonstrated an SCNC. Positron-emission tomography computed tomography confirmed primary vaginal SCNC with no metastatic foci. The patient subsequently underwent localized excision and was recommended for systemic treatment after a multidisciplinary team discussion. Following the first reported case many years ago, only a small number of cases have been documented in the medical literature. Due to the paucity of publications on SCNC of the vagina, there is currently no consensus on standard treatment protocols for this tumor. Therefore, we aim to raise awareness and research on this unique presentation of SCNC of the vagina.

Indexed as

extrapulmonary neuroendocrine neoplasmimmunohistochemical diagnostic markerski-67 in neuroendocrine tumorsneuroendocrine tumorprimary vaginal cancersmall-cell neuroendocrine vaginal carcinoma

Identifiers

PMID41333490
PMCPMC12667930

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.